314
Views
2
CrossRef citations to date
0
Altmetric
Drug Profile

Ertugliflozin for treatment of patients with Type 2 diabetes mellitus

Pages 747-753 | Received 08 Apr 2018, Accepted 18 Jul 2018, Published online: 31 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Parvej Khan, Shubhashree Venkatesh, Rizwana Parveen, Pinki Mishra, Seema Jain & Nidhi Agarwal. (2023) Longitudinal efficacy of Ertugliflozin in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Expert Opinion on Pharmacotherapy 0:0, pages 1-12.
Read now
Nasir Shah, Vlado Perkovic & Sradha Kotwal. (2022) Impact of SGLT2 inhibitors on the kidney in people with type 2 diabetes and severely increased albuminuria. Expert Review of Clinical Pharmacology 15:7, pages 827-842.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.